Research across Pelvic organ prolapse
Related studies from across the Pelvic organ prolapse family.
7 trials tracked for vaginal prolapse: 3 in phase 3 or 4 and 1 with published results. The most-cited published study has 23 citations.
Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →
Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.
Clinical evidence for the management of vaginal prolapse includes surgical interventions and topical treatments. The use of synthetic polypropylene mesh was evaluated for objective treatment success in anterior prolapse, with results showing a primary outcome measure of Point Ba at Stage 0 or 1 (maximal descent of the anterior wall to greater than 1 cm above the hymen) at one year 3.
Non-surgical interventions have also been studied. Conjugated Estrogens Cream was evaluated in a Phase 4 trial 1. Additionally, a water-based vaginal lubricant demonstrated specific voiding metrics with a percentage of voiding efficiency reaching 94.6 and 95.9 2.
AI synthesis of 5 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.
Related studies from across the Pelvic organ prolapse family.